Latest News about Biotechnology
Recent news which mentions Biotechnology
Pfizer delays its FDA application to expand its Covid vaccine to kids under 5 until April
February 11, 2022
From CNBC.com News
No one knows when the pandemic will end after omicron upended most hope of returning to normal
February 11, 2022
From CNBC.com News
FDA committee votes against Eli Lilly cancer treatment over concerns trials conducted only in China
February 10, 2022
From CNBC.com News
The CDC still needs to approve young kids' Covid shots, but it's telling health agencies to expect delivery by Feb. 21
February 09, 2022
From CNBC.com News
Watch live: New York Gov. Hochul is expected to lift indoor mask mandate
February 09, 2022
From CNBC.com News
Biotech ETFs Muddled Despite Amgen Strength
February 08, 2022
From ETF Trends
WHO says omicron BA.2 subvariant will rise globally, but scientists don't know if it can reinfect people
February 08, 2022
From CNBC.com News
Pfizer CEO says chances are 'very high' FDA will approve low-dose Covid shots for kids under 5
February 08, 2022
From CNBC.com News
From CNBC.com News
Though rare, Moderna Covid vaccine recipients have higher risk of heart inflammation than Pfizer
February 04, 2022
From CNBC.com News
Moderna's Covid vaccine for teens awaits OK as regulators review heart inflammation risk
February 04, 2022
From CNBC.com News
Merck expects to sell $5 billion to $6 billion of its new Covid treatment pill in 2022
February 03, 2022
From CNBC.com News
Artemis DNA Clinical Medical Laboratory Receives Second Accreditation From the College of American Pathologists
February 02, 2022
From PRUnderground
Pfizer starts submitting data for FDA emergency approval of vaccine for kids under 5
February 01, 2022
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.